172.67
price down icon3.08%   -5.46
 
loading

Krystal Biotech Inc Azioni (KRYS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
7.37%
45.25
42.14 8.556 - -
Operating Expenses
33.15%
51.93
39.01 34.55 38.05 48.82
Benefits Costs and Expenses
100.00%
-
37.80 - - -
Costs And Expenses
162.11%
51.93
-83.62 34.55 - -
Operating Income/Loss
313.00%
-6.684
3.138 -25.99 -38.05 -48.82
Income/Loss From Continuing Operations Before Tax
942.39%
45.25
4.341 8.556 -33.21 -45.30
Income/Loss From Continuing Operations After Tax
89.28%
0.932
8.692 80.75 -33.21 -45.30
Net Income/Loss
89.28%
0.932
8.692 80.75 -33.21 -45.30
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8,176%
28.30
0.3419 28.04 26.66 25.71
Diluted Average Shares
7,875%
29.29
0.3673 28.89 26.66 25.71
Basic Earnings Per Share
90.63%
0.03
0.32 2.88 -1.25 -1.76
Diluted Earnings Per Share
90.32%
0.03
0.31 2.79 -1.25 -1.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
Capitalizzazione:     |  Volume (24 ore):